+90 (532) 215 60 39 - İstanbul - TURKEY - c79gmd@utemparadoks.com

(C79-GMD) and ARTERIOSCLEROSIS

Diyabetik Retinopaty                                              Diyabetik Foot                                                           Diyabetik Nefropaty

WHAT İS (C79-GMD)?

 (C79-GMD) is a liquid elixir, which is made of composition of 9 different vegetables and flowers rooted, used to treat arteriosclerosis – aterom plaque disease that is known as embolism in public.

Some of these materials are frequently used in daily life, and considering the amounts of usage, they carry no risk, threat or any side effects for human health.

WHAT DOES (C79-GMD) DO AND HOW DOES IT TREAT?

(C79-GMD) reduces and removes embolism and aterom plaques by activating a pre-existing mechanism in the body. Namely, because embolism will lessen the blood circulation,(C79-GMD) enables an effected organ to function normally by adjusting blood circulation. This is a 30–years old  discovery as of 2009. In the lights of our knowledge, we accept that (C79-GMD) acts as a trigger to remove existing arteriosclerosis-aterom plaque-vessel lessening in human body.

THE DISEASES THAT (C79-GMD) CAN TREAT?

1-(C79-GMD) can be used in the definite treatment of diabetics caused by arteriosclerosis arises from vessel lessening complications. (Diabetic retinopathy, diabetic nephropathy, leg-neuropathy, coronary artery disease, burger, irregular erection due to diabetes, discomfort at nights, paralyses due to vessel lessening, frigidity, loss of sense, darkness on skin, ingestion problems, etc.). It is also assumed that (C79-GMD) can be used for patients who suffer from Alzheimer’s disease and Multiple Sclerosis. But it has not been tried on Alzheimer and Multiple Sclerosis patients. Our research has been continuing on these cases.

2-(C79-GMD) is used in the definite treatment of the other vessel lessening diseases for nondiabetics.

3-(C79-GMD) is used in the definite treatment of the coronary artery disease, glaucoma, burger, other arteriosclerosis-vessel lessening which form in other regions and organs such as brain, kidney, leg, etc.

It is known that the liquid called (C79-GMD) is not related to any subject or disease other than to treat vessel lessening (arteriosclerosis/ aterom plaque).

IMPORTANT NOTE: Between October 2004 and February 2007, 3 patients who had complained about the diabetes arised from complications caused by vessel lessening, and one nondiabetic patient who had complained about vessel lessening informed us that they had no longer had problems following the application of (C79-GMD). These patients whose prostate problems were clinically confirmed had also informed us that they had no longer complaints about prostat.

When these persons were re-examined by the physicians who diagnosed the prostat initially, the Physicians reported that the prostat was recovered and the they could give no meaning. Our research continuous on this uncertain subject .

THE CONTINUITY OF THE TREATMENT THAT IS OBTAINED BY  (C79-GMD)?

It is accepted that (C79-GMD) has a long time effect and prevents repetation of diseases so that contributes to a healthy life.

According to the literature, it is supposed that this period may be approximately 30 years. However, since (C79-GMD) has been known for 30 years, the recovery period will last for 30 years.

It is accepted that this period can become shorter due to the risk factors (diabetus, obesity). (For instance, this period is about 10 years for the diabetics)

THE SIDE AND TOXIC EFFECTS OF (C79-GMD)?

When the ingredients and their dosage of (C79-GMD) are taken into consideration, it is known that it is not harmful for humans. It does not contain toxic materials. It is received no any complaints including allergy in 30 years. It is assumed that there is no side effect.

HOW MANY PEOPLE  HAVE USED (C79-GMD) AND WHAT HAVE THE RESULTS BEEN?

(C79-GMD) is used by 600 people since its discovery. The complaints which arise from vessel lessening are treated in all patients. Success rate is 100 %.

THE INSTRUCTION TO USE (C79-GMD) AND ITS DOSAGE  

(C79-GMD) is preferrably taken orally on an empty stomach. However, if it is taken with full stomach, its action time does not change significantly. The dosage should be between 30 and 50 cc depending on the rate of vessel lessening, age, the course of the disease, and the anamnesis of patients. It is useful to know that this dosage is not a result of a formal scientific study.

It is konwn that (C79-GMD) gives rise to an outcome of  dilating-cleaning-obtaining blood circulation approximately 40% in all areas that let blood circulation by each dosage taken. The rate of 40 % is an approximation, and is not a rate determined at the end of a formal-scientific study.

As an example, a brief information on the improvement of using 2nd dose of (C79-GMD) on an artery in which a 60% lessening was diagnosed is given below.

(C79-GMD) 1.DOSAGE, VESSEL LESSENING RATE TABLE

The following of the first dose taken, for instance, within first 4 hours, the lessening rate which is determined as 60% will decrease to 44% and the open area in the vessel that let blood flowing will rise from 40% to 56%. The patient feels more than the real values indicate in his/her life within just four hours. Some patients may even give up to use the reamining dosage because they recover completely. There is a dilation for 40 % in the area that enables the blood circulation.

 The interaction between (C79-GMD) and body continues nearly 7 days following the first dosage used. After using (C79-GMD), the urine of the patient starts forming  to be oily and fizzy for short or long time depending on the dispersion level of the vessel lessening in the body. The fizzy/oily urine starts to decline gradually and turns to be normal after approximately 7 days. The second dose of (C79-GMD) is used after 7 days or following the day the urine becomes normal.

This is the general principle in the usage of all doses.

(C79-GMD) 2.DOSAGE, VESSEL LESSENING RATE TABLE

With the available information, the required amount of (C79-GMD) to use depending on the rate of lessening is shown in the table below. (Since no discomfort is felt below 30%lessening, the decision to use (C79-GMD) in this case is up to patient and physician) You may determine the dose of (C79-GMD) by making the use of formula mentioned above. 

The required doses with related to lessening rate is given below.

This recovery period by (C79-GMD) continues approximately 10 years in controlled diabetics, and 30 years in patients who have other vessel lessening diseases such as coronary artery, and burger.

THE USE OF (C79-GMD) IN OUT OF DISORDER

Assuming that all people have the problem of vessel lessening, it is known that there is no need to avoid to use it for unawared vessel lessening. These people who do not feel the discomfort caused by vessel lessening will not feel any change in their body in the post (C79-GMD) period.  

HOW CAN I FIND (C79-GMD)?

If your treatment is possible by legal drugs, as a matter of fact, your physicians will prescribe the proper drugs and treat you. If there is no any legal drugs that will treat you, we’d like you to receive an official letter which indicates that “your disease can not be treated with available drugs” approved by your organization.

After we receive your approved official letter, you should come to Istanbul. You will fill out and sign the necessary forms and documents, use (C79-GMD) and go back home in relief.  

THE INSTRUCTIONS FOR POST USE OF (C79-GMD)

THE DIABETES MELLITUS PATIENTS THAT USE INSULIN: Diabetics should have their physicians checked their insulin dosage again since renal filtration will be at lower levels. Because the need of the body for insulin will decline. Patients should know that the blood sugar will dramatically drop if they continue to use the same amount of insulin as before. That means, the need of 60 units of insulin for a typical diabetic will decline to 20 units after using (C79-GMD). Please pay attention to this.

ALL (C79-GMD) USERS WHO WEAR GLASSES:   All (C79-GMD) users who wear glasses should have their glasses checked to an ophthalmologist post use of (C79-GMD). Because the reduction in the visual ability will vanish by the use of (C79-GMD), they may not see well with their existing glasses. Patients may usually be adapted to new positive developments by reducing the grade of their glasses for post examination period. That means, because there will be recovery in eyes after the use of (C79-GMD), it is necessity to have an ophthalmologist to check the glasses.

THE PATIENTS ON WHOM LASER IS APPLIED:  (C79-GMD) will not affect laser-applied eye of a patient because of the quality of the laser applied. Because (C79-GMD) can not be expected to be effective on the cut, abandoned, and obliterated vessels by laser.      

.